Dhakal Reflects on the FDA Approval of Cilta-Cel for Earlier Lines of RRMM Binod Dhakal, MD, MS;Jordyn Sava June 14th 2024 Podcast In this episode of Targeted Talks, Binod Dhakal, MD, MS, discusses the recent FDA approval of ciltacabtagene autoleucel for the treatment of relapsed/refrac...
OS With Chemotherapy Is Linked With Baseline Geriatric, QOL Factors in Metastatic Pancreatic Cancer November 29th 2024 FDA Approval Insights: Obe-Cel in B-Cell Precursor ALL January 29th 2025 Blood Test Could Guide Use of Anti-Inflammatory Drug Celecoxib to Reduce Risk...
Dr Moore on the 2024 FDA Approval of Mirvetuximab Soravtansine in Ovarian Cancer Dr Yaeger on the Efficacy of Adagrasib/Cetuximab in KRAS G12C+ mCRC Dr Ascierto on First-Line Treatment Selection in Advanced BRAF+ MelanomaRelated Content OncLive TVMultiple MyelomaConferenceASH Annual...
Dhakal Reflects on the FDA Approval of Cilta-Cel for Earlier Lines of RRMM Binod Dhakal, MD, MS;Jordyn Sava June 14th 2024 Podcast In this episode of Targeted Talks, Binod Dhakal, MD, MS, discusses the recent FDA approval of ciltacabtagene autoleucel for the treatment of relapsed/refra...